1629P Lutetium-177–prostate-specific membrane antigen (177Lu-PSMA) therapy in patients (pts) with prior Radium-223 (223Ra)

Autor: Rahbar, K., Sarfaty, M., Peer, A., Leibowitz, R., Eiber, M., la Fougère, C., Prasad, V., Fendler, W.P., Rassek, P., Hasa, E., Dittmann, H., Bundschuh, R.A., Pabst, K.M., Kurtinecz, M., Korn, M., Essler, M., Sartor, O.
Zdroj: In Annals of Oncology September 2024 35 Supplement 2:S983-S984
Databáze: ScienceDirect